In a blow to the country’s plans to escalate local production of Gilead’s revolutionary lenacapavir HIV prevention shot, South Africa’s biggest pharmaceutical manufacturer, Aspen Pharmacare, has pulled out of government plans for local production of the jab, reports Business Day. It cites a lack of guaranteed demand as the reason behind the decision, saying it […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.